The large Rep protein of adeno-associated virus type 2 is polyubiquitinated

References

1. Berns K. I., Giraud C. 1996; Biology of adeno-associated virus. Curr Top Microbiol Immunol 218:1–23[PubMed]
   [Google Scholar]
2. Blanchette P., Branton P. E. 2009; Manipulation of the ubiquitin-proteasome pathway by small DNA tumor viruses. Virology 384:317–323 [View Article][PubMed]
   [Google Scholar]
3. Bowles D., Rabinowitz J. E., Samulski R. J. 2006; The genus Dependoviruses. In Parvoviruses pp. 15–24 Edited by Kerr J. R., Cotmore S. F. London, UK: Hodder Arnold;
   [Google Scholar]
4. Chew E. H., Hagen T. 2007; Substrate-mediated regulation of cullin neddylation. J Biol Chem 282:17032–17040 [View Article][PubMed]
   [Google Scholar]
5. Ciechanover A. 1998; The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 17:7151–7160 [View Article][PubMed]
   [Google Scholar]
6. Conze D. B., Wu C. J., Thomas J. A., Landstrom A., Ashwell J. D. 2008; Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-κB activation. Mol Cell Biol 28:3538–3547 [View Article][PubMed]
   [Google Scholar]
7. Farris K. D., Fasina O., Sukhu L., Li L., Pintel D. J. 2010; Adeno-associated virus small rep proteins are modified with at least two types of polyubiquitination. J Virol 84:1206–1211 [View Article][PubMed]
   [Google Scholar]
8. Hunter L. A., Samulski R. J. 1992; Colocalization of adeno-associated virus rep and capsid proteins in the nuclei of infected cells. J Virol 66:317–324[PubMed]
   [Google Scholar]
9. Komander D. 2009; The emerging complexity of protein ubiquitination. Biochem Soc Trans 37:937–953 [View Article][PubMed]
   [Google Scholar]
10. Lim K. L., Chew K. C., Tan J. M., Wang C., Chung K. K., Zhang Y., Tanaka Y., Smith W., Engelender S. et al.& other authors ( 2005; Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J Neurosci 25:2002–2009 [View Article][PubMed]
    [Google Scholar]
11. Lim K. L., Dawson V. L., Dawson T. M. 2006; Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson’s and other conformational diseases?. Neurobiol Aging 27:524–529 [View Article][PubMed]
    [Google Scholar]
12. Nash K., Chen W., Salganik M., Muzyczka N. 2009; Identification of cellular proteins that interact with the adeno-associated virus rep protein. J Virol 83:454–469 [View Article][PubMed]
    [Google Scholar]
13. Nayak R., Pintel D. J. 2007; Positive and negative effects of adenovirus type 5 helper functions on adeno-associated virus type 5 (AAV5) protein accumulation govern AAV5 virus production. J Virol 81:2205–2212 [View Article][PubMed]
    [Google Scholar]
14. Nayak R., Farris K. D., Pintel D. J. 2008; E4Orf6-E1B-55k-dependent degradation of de novo-generated adeno-associated virus type 5 Rep52 and capsid proteins employs a cullin 5-containing E3 ligase complex. J Virol 82:3803–3808 [View Article][PubMed]
    [Google Scholar]
15. Olzmann J. A., Li L., Chudaev M. V., Chen J., Perez F. A., Palmiter R. D., Chin L. S. 2007; Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J Cell Biol 178:1025–1038 [View Article][PubMed]
    [Google Scholar]
16. Pickart C. M. 1997; Targeting of substrates to the 26S proteasome. FASEB J 11:1055–1066[PubMed]
    [Google Scholar]
17. Sheaff R. J., Singer J. D., Swanger J., Smitherman M., Roberts J. M., Clurman B. E. 2000; Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell 5:403–410 [View Article][PubMed]
    [Google Scholar]
18. Weger S., Hammer E., Heilbronn R. 2004; SUMO-1 modification regulates the protein stability of the large regulatory protein Rep78 of adeno associated virus type 2 (AAV-2). Virology 330:284–294 [View Article][PubMed]
    [Google Scholar]